Table 2.
Demographic data for reactive versus non-reactive subjects
| Demographic data between non-reactive and reactive subjects | |||
|---|---|---|---|
| Non-reactive (n = 6) | Reactive (n = 8) | p-value | |
| Age (years) | 17 ± 4.1 | 8.5 ± 5.1 | 0.006 |
| Female:male | 4:2 | 4:4 | |
| Length of disease (years) | 10.3 ± 6 | 5.7 ± 3.8 | 0.1 |
| Pulmonary hypertension classification | |||
| 1. Pulmonary arterial hypertension | 6 | 6 | |
| 1.1 Idiopathic | 1 | 3 | |
| 1.3 Drug and toxin-induced | 1 | ||
| 1.4.1 Connective tissue disorder | 1 | ||
| 1.4.4 Congenital heart disease | 3 | 2 | |
| 1.4.5 Pulmonary hypertension from schistosomiasis | 1 | ||
| 3. Pulmonary hypertension due to lung disease | 2 | ||
| PVRi (Woods unit x m2) | 13.8 ± 11 | 6.1 ± 2.7 | 0.08 |
| RVEDVi (ml/m2) | 162 ± 61 | 100 ± 25 | 0.02 |
| RVEF (%) | 40 ± 14 | 50 ± 2.9 | 0.07 |
| VVCRm | 1.8 ± 1.0 | 1.0 ± 0.11 | 0.04 |
Abbreviations: PVRi pulmonary vascular resistance indexed, RVEDVi right ventricular end-diastolic volume indexed, RVEF right ventricular ejection fraction